Lewis, M.M.; Van Scoy, L.J.; De Jesus, S.; Hakun, J.G.; Eslinger, P.J.; Fernandez-Mendoza, J.; Kong, L.; Yang, Y.; Snyder, B.L.; Loktionova, N.;
et al. Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease. Biomolecules 2023, 13, 829.
https://doi.org/10.3390/biom13050829
AMA Style
Lewis MM, Van Scoy LJ, De Jesus S, Hakun JG, Eslinger PJ, Fernandez-Mendoza J, Kong L, Yang Y, Snyder BL, Loktionova N,
et al. Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease. Biomolecules. 2023; 13(5):829.
https://doi.org/10.3390/biom13050829
Chicago/Turabian Style
Lewis, Mechelle M., Lauren J. Van Scoy, Sol De Jesus, Jonathan G. Hakun, Paul J. Eslinger, Julio Fernandez-Mendoza, Lan Kong, Yang Yang, Bethany L. Snyder, Natalia Loktionova,
and et al. 2023. "Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease" Biomolecules 13, no. 5: 829.
https://doi.org/10.3390/biom13050829
APA Style
Lewis, M. M., Van Scoy, L. J., De Jesus, S., Hakun, J. G., Eslinger, P. J., Fernandez-Mendoza, J., Kong, L., Yang, Y., Snyder, B. L., Loktionova, N., Duvvuri, S., Gray, D. L., Huang, X., & Mailman, R. B.
(2023). Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease. Biomolecules, 13(5), 829.
https://doi.org/10.3390/biom13050829
